Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426M Sell
1,072,296
-21,480
-2% -$6.12M 0.08% 209
2026
Q1
$190M Sell
1,093,776
-90,435
-8% -$18.5M 0.04% 379
2025
Q4
$303M Buy
1,184,211
+9,528
+0.8% +$2.5M 0.06% 267
2025
Q3
$306M Sell
1,174,683
-181,628
-13% -$47.8M 0.07% 267
2025
Q2
$332M Buy
1,356,311
+219,773
+19% +$54.8M 0.07% 273
2025
Q1
$301M Buy
1,136,538
+158,528
+16% +$42.9M 0.08% 272
2024
Q4
$248M Buy
978,010
+121,056
+14% +$32.5M 0.06% 317
2024
Q3
$271M Buy
856,954
+9,100
+1% +$3.24M 0.07% 265
2024
Q2
$317M Buy
847,854
+112,513
+15% +$38M 0.09% 201
2024
Q1
$255M Sell
735,341
-4,164
-0.6% -$1.58M 0.09% 224
2023
Q4
$339M Buy
739,505
+10,088
+1% +$4.97M 0.13% 152
2023
Q3
$355M Sell
729,417
-101,552
-12% -$47.7M 0.16% 133
2023
Q2
$403M Hold
830,969
0.2% 109
2023
Q1
$403M Buy
830,969
+8,485
+1% +$4.19M 0.2% 109
2022
Q4
$421M Buy
822,484
+8,827
+1% +$4.64M 0.22% 100
2022
Q3
$395M Buy
813,657
+43,737
+6% +$21.3M 0.22% 93
2022
Q2
$360M Sell
769,920
-2,148
-0.3% -$956K 0.19% 112
2022
Q1
$336M Buy
772,068
+30,363
+4% +$12.7M 0.14% 142
2021
Q4
$344M Sell
741,705
-43,071
-5% -$19.1M 0.13% 170
2021
Q3
$305M Buy
784,776
+8,551
+1% +$3.63M 0.13% 170
2021
Q2
$344M Sell
776,225
-81,622
-10% -$35.7M 0.15% 150
2021
Q1
$360M Buy
857,847
+31,449
+4% +$12.6M 0.16% 130
2020
Q4
$339M Buy
826,398
+59,272
+8% +$24.6M 0.16% 124
2020
Q3
$318M Buy
767,126
+63,125
+9% +$25.4M 0.17% 116
2020
Q2
$273M Buy
704,001
+135,726
+24% +$50.8M 0.17% 121
2020
Q1
$178M Buy
568,275
+14,449
+3% +$4.87M 0.13% 157
2019
Q4
$203M Buy
553,826
+26,649
+5% +$8.45M 0.12% 171
2019
Q3
$135M Buy
527,177
+19,717
+4% +$5.53M 0.09% 236
2019
Q2
$135M Sell
507,460
-30,940
-6% -$7.85M 0.1% 229
2019
Q1
$143M Sell
538,400
-119,846
-18% -$34.5M 0.11% 208
2018
Q4
$189M Sell
658,246
-18,509
-3% -$5.87M 0.16% 126
2018
Q3
$229M Sell
676,755
-63,318
-9% -$20.6M 0.17% 125
2018
Q2
$220M Sell
740,073
-13,911
-2% -$4.07M 0.17% 127
2018
Q1
$203M Buy
753,984
+29,721
+4% +$8.05M 0.16% 137
2017
Q4
$180M Sell
724,263
-40,220
-5% -$9.93M 0.15% 144
2017
Q3
$186M Sell
764,483
-8,288
-1% -$2.03M 0.17% 125
2017
Q2
$186M Buy
772,771
+314,086
+68% +$71.1M 0.18% 126
2017
Q1
$94.6M Buy
458,685
+44,113
+11% +$9.12M 0.1% 235
2016
Q4
$84.6M Buy
414,572
+25,639
+7% +$4.89M 0.09% 234
2016
Q3
$68.8M Sell
388,933
-11,880
-3% -$2.06M 0.07% 288
2016
Q2
$72.1M Sell
400,813
-1,556
-0.4% -$276K 0.08% 265
2016
Q1
$73.6M Sell
402,369
-36,281
-8% -$6.29M 0.09% 259
2015
Q4
$78.3M Sell
438,650
-83,731
-16% -$14.7M 0.09% 246
2015
Q3
$93.5M Sell
522,381
-53,031
-9% -$9.8M 0.1% 219
2015
Q2
$110M Sell
575,412
-230
-0% -$42.7K 0.11% 216
2015
Q1
$102M Sell
575,642
-24,067
-4% -$3.81M 0.1% 231
2014
Q4
$86.1M Sell
599,709
-91,533
-13% -$12.5M 0.08% 265
2014
Q3
$90.1M Buy
691,242
+15,251
+2% +$1.94M 0.09% 251
2014
Q2
$86.3M Sell
675,991
-8,440
-1% -$1,000K 0.09% 260
2014
Q1
$77.1M Buy
684,431
+106,948
+19% +$11.1M 0.08% 272
2013
Q4
$59.6M Buy
577,483
+10,727
+2% +$1.05M 0.07% 314
2013
Q3
$52.9M Sell
566,756
-34,856
-6% -$3.2M 0.07% 314
2013
Q2
$50.8M Buy
+601,612
New +$47.5M 0.07% 311

Other funds holding HUM

UBS AM's HUM Position: Q2 2026 in Review

UBS AM reduced its Humana (HUM) stake by 2% in Q2 2026, selling an estimated $6.12M and leaving 1,072,296 shares worth $426M. The position accounts for 0.08% of the portfolio, ranked #209.

UBS AM first reported a position in HUM in Q2 2013 and has held it in 53 quarters since. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • UBS AM held 1,072,296 shares of Humana worth $426M as of Q2 2026.
  • UBS AM sold 21,480 Humana shares in Q2 2026, an estimated $6.12M.
  • Humana made up 0.08% of UBS AM's portfolio in Q2 2026, its #209 holding.
  • UBS AM first reported a position in Humana in Q2 2013 and has held it in 53 quarters since.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.